Respiratory effects of buprenorphine/naloxone alone and in combination with diazepam in naive and tolerant rats

•Like buprenorphine alone, buprenorphine/naloxone does not depress ventilation in rats.•IV buprenorphine/naloxone injection induces withdrawal symptoms in tolerant rats.•Naloxone does not prevent the deleterious respiratory effects of buprenorphine/diazepam. Respiratory depression has been attribute...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Toxicology letters 2014-07, Vol.228 (2), p.75-84
Hauptverfasser: Cohier, Camille, Chevillard, Lucie, Risède, Patricia, Roussel, Olivier, Mégarbane, Bruno
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:•Like buprenorphine alone, buprenorphine/naloxone does not depress ventilation in rats.•IV buprenorphine/naloxone injection induces withdrawal symptoms in tolerant rats.•Naloxone does not prevent the deleterious respiratory effects of buprenorphine/diazepam. Respiratory depression has been attributed to buprenorphine (BUP) misuse or combination with benzodiazepines. BUP/naloxone (NLX) has been marketed as maintenance treatment, aiming at preventing opiate addicts from self-injecting crushed pills. However, to date, BUP/NLX benefits in comparison to BUP alone remain debated. We investigated the plethysmography effects of BUP/NLX in comparison to BUP/solvent administered by intravenous route in naive and BUP-tolerant Sprague-Dawley rats, and in combination with diazepam (DZP) or its solvent. In naive rats, BUP/NLX in comparison to BUP significantly increased respiratory frequency (f, P
ISSN:0378-4274
1879-3169
DOI:10.1016/j.toxlet.2014.04.009